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Abstract 12 
Identification of those at greatest risk of death due to the substantial threat of COVID-19 can 13 
benefit from novel approaches to epidemiology that leverage large datasets and complex 14 
machine-learning models, provide data-driven intelligence, and guide decisions such as 15 
intensive-care unit admission (ICUA). The objective of this study is two-fold, one substantive 16 
and one methodological: substantively to evaluate the association of demographic and health 17 
records with two related, yet different, outcomes of severe COVID-19 (viz., death and ICUA); 18 
methodologically to compare interpretations based on logistic regression and on gradient-19 
boosted decision tree (GBDT) predictions interpreted by means of the Shapley impacts of 20 
covariates. Very different association of some factors, e.g., obesity and chronic respiratory 21 
diseases, with death and ICUA may guide review of practice. Shapley explanation of GBDTs 22 
identified varying effects of some factors among patients, thus emphasising the importance 23 
of individual patient assessment. The results of this study are also relevant for the evaluation 24 
of complex automated clinical decision systems, which should optimise prediction scores 25 
whilst remaining interpretable to clinicians and mitigating potential biases. 26 
Author summary 27 
The design is a retrospective cohort study of 13954 in-patients of ages ranging from 1 to 105 28 
year (IQR: 56, 70, 81) with a confirmed diagnosis of COVID-19 by 28th June 2020. This study 29 
used multivariable logistic regression to generate odd ratios (ORs) multiply adjusted for 37 30 
covariates (comorbidities, demographic, and others) selected on the basis of clinical interest 31 
and prior findings. Results were supplemented by gradient-boosted decision tree (GBDT) 32 
classification to generate Shapley values in order to evaluate the impact of the covariates on 33 
model output for all patients. Factors are differentially associated with death and ICUA and 34 
among patients. 35 
Deaths due to COVID-19 were associated with immunosuppression due to disease (OR 1.39, 36 
95% CI 1.10-1.76), type-2 diabetes (OR 1.31, 95% CI 1.17-1.46), chronic respiratory disease 37 
(OR 1.19, 95% CI 1.05-1.35), age (OR 1.56/10-year increment, 95% CI 1.52-1.61), and male sex 38 
(OR 1.54, 95% CI1.42-1.68). Associations of ICUA with some factors differed in direction (e.g., 39 
age, chronic respiratory disease). Self-reported ethnicities were strongly but variably 40 
associated with both outcomes. 41 
GBDTs had similar performance (ROC-AUC, ICUA 0.83, death 0.68 for GBDT; 0.80 and 0.68 for 42 
logistic regression). We derived importance scores based on Shapley values which were 43 
consistent with the ORs, despite the underlying machine-learning model being intrinsically 44 
different to the logistic regression. Chronic heart disease, hypertension, other comorbidities, 45 
and some ethnicities had Shapley impacts on death ranging from positive to negative among 46 
different patients, although consistently associated with ICUA for all. Immunosuppressive 47 
disease, type-2 diabetes, and chronic liver and respiratory diseases had positive impacts on 48 
death with either positive or negative on ICUA. 49 
We highlight the complexity of informing clinical practice and public-health interventions. We 50 
recommend that clinical support systems should not only predict patients at risk, but also 51 
yield interpretable outputs for validation by domain experts. 52 
Introduction 53 
COVID-19, due to SARS-CoV-2 betacoronavirus, emerged in Wuhan, China in late 2019 and 54 
has spread globally. It can cause severe complications of pneumonia, acute respiratory 55 
distress syndrome, sepsis, and septic shock1. It has, as of October 24, 2020, infected over 42 56 
million people and killed over 1.1 million people2. Certain patient subsets, such as the elderly 57 
and those with comorbidities, are at an increased risk of severe outcomes from COVID-19 58 
such as admission to intensive care units, respiratory distress requiring mechanical 59 
ventilation, and death3,4. 60 
Clinicians can use predictive factors to prioritize patients at higher risk of clinical deterioration 61 
and public health authorities can use them to target public health interventions. Identifying 62 
factors associated with severe disease has been described as an urgent research priority. 63 
Several studies have sought to identify factors predicting poor outcome following COVID-19 64 
infection5,6 and assist clinician decision making7–9.  A traditional method such as logistic 65 
regression can infer the odd ratios (ORs) of the outcome in the presence of a risk factor. 66 
Modern machine-learning technologies, widely implemented during the COVID-19 pandemic, 67 
can handle more complex patient data types, offer greater generality, and produce more 68 
accurate predictions than the previous methods, but at the cost of losing transparency and 69 
interpretability10. 70 
Surveillance systems support these analyses. The COVID-19 Hospitalization in England 71 
Surveillance System (CHESS), a UK system distributed by Public Health England (PHE) and 72 
adapted from the UK severe influenza surveillance system, collects extensive data on patients 73 
admitted to hospital,  including known comorbidities and important demographic 74 
information (such as age, sex, and ethnicity)11. This large national dataset reduces limitations 75 
inherent in small cohorts, enabling more reliable identification of associations. We performed 76 
analyses on this dataset using logistic regression and a more general machine-learning model 77 
(the gradient-boosted decision tree, GBDT), which generated interpretable predictions by 78 
means of the Shapley additive explanation, a technique thatmitigates the interpretability 79 
issue in machine-learning outputs. For different applications of this technique to COVID-19 80 
research see, e.g., references 12,13. Through these methods, we demonstrated the extent to 81 
which pre-existing conditions differentially predicted death and intensive care unit (ICU) 82 
admission. Some factors affected both similarly but others proved to be protective for one 83 
while increasing the risk for the other, or showed very different effect sizes. We also identified 84 
variation of effects among patients. These results may be useful to clinicians assessing 85 
hospitalized patients with COVID-19. They may also provide a greater context or benchmark 86 
for individuals evaluating or interpreting complex automated clinical decision systems 87 
designed to identify those most at-risk. 88 
Materials and methods 89 
Description of cohort and outcomes 90 
We studied a cohort of 13954 patients of which 8947 patients survived and 5007 died after 91 
contracting COVID-19. 5758 were admitted to ICUs, of whom 3483 were discharged after 92 
treatment, and 2275 died. The dataset includes epidemiological data (demographics, risk 93 
factors, and outcomes) on patients with a confirmed diagnosis of COVID-19 by 28th June 2020 94 
who required hospitalization. We included all available chronic and pre-existing morbid 95 
conditions recorded by PHE as potential risk factors, including immunosuppression due to 96 
disease, asthma requiring medication, immunosuppression due to treatment, neurological 97 
conditions, respiratory conditions, obesity, type-1 and type-2 diabetes, hypertension, heart 98 
conditions, renal disease, liver diseases, and other comorbidities11. No acute illnesses or 99 
medical conditions were considered. In the CHESS dataset self-defined ethnicity is categorized 100 
according to the Office for National Statistics questionnaires into 17 factors, all included in 101 
the study. With 8628 patients, white British was the largest group in the cohort and therefore 102 
chosen as a reference category. 1895 patients did not identify themselves with any ethnicity 103 
and were labelled as “NA”. With the exception of age and admission date, all features were 104 
stratified to binary variables. Entries labelled “diabetes” whose type was unknown and not 105 
recorded in the database as “type 1”, have been considered as “type 2”. Death and ICU 106 
admission were chosen as outcomes. The median age of this sample was 70 years (IQR 56-81, 107 
range 1-105), 59.25% were men and 0.18% had an unrecorded sex. The prevalence of 108 
comorbidities is reported in Table 1 and ethnicity in Table 2. Cross-correlations between 109 
recorded ethnicities and pre-existing conditions are illustrated in Figure 1. 110 
Statistical analysis 111 
Logistic regression models were used to estimate odd ratios (ORs) of all 37 pre-existing 112 
conditions and demographic factors for both outcomes. Standard errors (SEs) and confidence 113 
intervals (CIs) of the ORs were computed using the Taylor series-based delta method and the 114 
profile likelihood method, respectively, and statistical significance assessed using the 115 
Benjamini-Hochberg (BH) test with false discovery rate set to 0.0514.  116 
In addition, we applied a “gradient boosted decision tree” (GBDT) machine-learning model 117 
with logistic objective function, as an appropriate machine learning approach. A GBDT 118 
aggregates a large number of weak prediction models, in this case decision trees, into a robust 119 
prediction algorithm, where the presence of many trees mitigates the errors due to a single-120 
tree prediction. Each individual tree consists of a series of nodes that represent binary 121 
decision splits against one of the input variables, with its final output being determined by 122 
the nodes at the end of the tree (known as leaves). The model was implemented in the 123 
XGBoost library (version 0.81)23 and depended on a number of hyper-parameters. To avoid 124 
over-fitting, these hyper-parameters were selected by means of Bayesian optimization of c-125 
statistics using 5-fold cross-validation over the training set24 with constant L1-regularisation 126 
parameter 𝛼 = 0.5. We used Shapley additive explanation (SHAP) analysis to understand the 127 
result of a GBDT model fit15,16. The importance of each feature in the model output is 128 
represented by the so-called Shapley values, introduced in game theory literature and 129 
providing a theoretically justified method for allocation of credit among a group of players. In 130 
the context of machine learning, the same mathematics is used to allocate the credit for the 131 
GBDT prediction among the 𝑁 features included in the study, for each of the 𝑀 patients.The 132 
chief output of this approach is a 𝑀 × 𝑁 matrix of Shapley values 𝜙𝑖𝑗 where i indicates a 133 
patient, 𝑖 = 1,2, … , 𝑁, and j is a pre-existing condition or other patient characteristic, 𝑗 =134 
1,2, … , 𝑁. We also refer to the Shapley value 𝜙𝑖𝑗 as the impact of j on the outcome for the 135 
patient i. Similar to the logistic regression model, for each patient i, the trained GBDT model 136 
returns a decision value 𝑓𝑖 to be interpreted as the logarithm of the odds that the outcome is 137 
poor. The Shapley values are unique allocations of credit in explaining the decision 𝑓𝑖  among 138 
all the 𝑁 features, where for our case, negative values (𝜙𝑖𝑗 < 0) tip the decision value 139 
towards good outcome, while positive values (𝜙𝑖𝑗 > 0) towards bad (i.e., ICU or death). The 140 
model output satisfies 𝑓𝑖 = ∑ 𝜙𝑖𝑗
𝑁
𝑗=0  (which is the local accuracy property), where 𝜙𝑖0 is a bias 141 
term. Importantly, it has been mathematically proven that the Shapley allocation is the only 142 
possible one that satisfies two additional desirable properties, i.e., consistency (if a feature’s 143 
contribution increases or stays the same regardless of the other inputs, its Shapley value does 144 
not decrease), and missingness (a zero-valued feature contributes a zero Shapley value)15–17. 145 
In tree-based models, the same idea has been extended to allocate the credit to pairs of 146 




𝑘=0 , where the Φ𝑖𝑗𝑘s are referred to as SHAP 147 
interaction values16. The diagonal term Φ𝑖𝑗𝑗 encodes the net effect on the model prediction 148 
𝑓𝑖  of a feature j, stripped of its interactions with the other features 𝑘 ≠ 𝑗 and is referred to as 149 
the SHAP main effect of j.  We used an implementation specific to tree-based models, also 150 
referred to as TreeSHAP, accessible via the XGBoost and SHAP libraries; we refer the reader 151 
to references15,16 for a more comprehensive discussion and for the implementation details. 152 
Such an approach explains each individual prediction 𝑓𝑖  and is therefore referred to as a local 153 
method. In contrast to that, as a complementary global method, we consider the so-called 154 
partial dependence plots (PDPs) to show the average effects of age and admission date on 155 
the predicted outcomes, marginalizing over the values of all other features18. 156 
It is worth comparing this approach with the standard logistic regression. For a patient i with 157 
feature values  𝐗𝑖: = (𝑥𝑖1, 𝑥𝑖2, … , 𝑥𝑖𝑁), the logistic regression and the GPDT models predict an 158 
outcome (here taken to be ICUA or death) with probabilities 𝑝(𝐗𝑖) and 𝑝(𝐗𝑖), respectively. 159 








1 − 𝑝 (𝐗𝑖)
=: 𝑓𝑖 = 𝜙𝑖0 + 𝜙𝑖1 + 𝜙𝑖2 + ⋯ + 𝜙𝑖𝑁 , 163 
where the coefficients 𝛽𝑗sare maximum-likelihood estimates and the values 𝜙𝑖𝑗s are obtained 164 
by means of the TreeSHAP algorithm. To rank the features by their overall importance, we 165 
estimate the slopes 𝝓𝑗  𝐱𝑗
𝑇/(𝐱𝑗𝐱𝑗
𝑇) for each j, where 𝝓𝑗: = (𝜙1𝑗 , 𝜙2𝑗 , … , 𝜙𝑁𝑗) and 𝐱𝑗: =166 
(𝑥1𝑗 , 𝑥2𝑗 , … , 𝑥𝑁𝑗), thus obtaining a novel feature score which we refer to as 𝐼𝑚𝑝𝑗 and can be 167 
directly compared to the coefficient 𝛽𝑗. 168 
All models were fitted to a randomly chosen 90% of data entries, while the remaining entries 169 
were used for validation. Goodness-of-prediction was assessed by means of the c-statistics of 170 
the receiver operating characteristic curve (ROC-AUC) on the validation set, with 171 
bootstrapped 2.5%-97.5% confidence intervals. 172 
Results 173 
Risk factors showed strong associations with both death and ICUA, but the strength and even 174 
direction of these associations differed substantially across these outcomes. From logistic 175 
regression analysis, immunosuppression due to disease (OR 1.39, 95% CI 1.10-1.76), type-2 176 
diabetes (OR 1.31, 95% CI 1.17-1.46), chronic respiratory disease (OR 1.19, 95% CI 1.05-1.35), 177 
age (OR 1.56 for each 10 year age increment, 95% CI 1.51-1.61), and being male (OR 1.54, 178 
95% CI 1.42-1.68) were strongly associated with deaths due to COVID-19. The regression was 179 
adjusted for other comorbidities including type-1 diabetes, chronic liver disease, serious 180 
mental illness, chronic renal disease, chronic neurological condition, chronic heart disease, 181 
hypertension, obesity and asthma, none of which were significantly associated with death 182 
(BH test). Having any comorbidity other than these was recorded in the dataset as “other 183 
comorbidity” and appeared to be a protective factor (OR death, 0.87, 95% CI 0.79-0.95). Some 184 
self-reported ethnicities, compared to white British, were associated with substantially 185 
increased risk of death (e.g., Indian (OR 1.84, 95% CI 1.42-2.73)) risk of death. Asymptomatic 186 
testing was associated with substantially lower risk of death (OR 0.29, 95% CI 0.18-0.45). The 187 
estimated ORs of deaths are detailed in Table 3 and illustrated in Figure S1. 188 
Among co-morbidities, obesity (OR 3.37, 95% CI 2.90-3.29), serious mental illness (OR 2.57, 189 
95% CI 1.51-4.46), hypertension (OR 1.58, 95% CI 1.42-1.76), asthma (OR 1.51, 95% CI 1.29-190 
1.77), and “other comorbidity” (OR 1.31, 95% CI 1.19-1.45) were strongly positively associated 191 
with ICU admission (Table 3, Figure S2). Each of these had far weaker or even negative 192 
associations with death. Some features associated with increased risk of death such as chronic 193 
respiratory disease were negatively associated with ICUA (OR 0.83, 95% CI 0.72-0.96). No 194 
ethnicity was negatively associated with ICUA compared to white British although there was 195 
substantial variation across these. Other factors associated with ICUA included 196 
immunosuppression due to treatment (OR 1.793, 95% CI 1.41-2.28) and male sex (OR 1.73, 197 
95% CI 1.58-1.89). Old age (OR 0.76, 95% CI 0.74-0.78 for each 10-year increment), 198 
asymptomatic testing (OR 0.52, 95% CI 0.35-0.74), and pregnancy (OR 0.34, 95% CI 0.20-0.57) 199 
were associated with decreased ICUA. The associations of each predictor with death and with 200 
ICUA are illustrated in Figure 2, highlighting some contrasts in direction and magnitude while 201 
other risk factors appear more consistently associated with the two outcomes. The overall 202 
associations obtained from the GBDT model were consistent with the logistic model results. 203 
The receiver operating characteristic (ROC) curves for the logistic regression models are 204 
plotted in Figure 3. The ROC-Area Under the Curve (AUC) scores for the logistic regression 205 
classifiers were 0.68 (95% CI 0.65-0.71) and 0.80 (95% CI 0.78-0.82) for death and ICUA 206 
outcome predictions, respectively. Generalized collinearity diagnostics by means of variance 207 
inflation factor (VIF) excluded severe collinearity (VIFs <2, Table 4, see also reference 19). The 208 
scores of GBDT for classification task were 0.68 (95% CI 0.66-0.71) and 0.83 (95% CI 0.82-0.85) 209 
for the death and ICUA outcome predictions, respectively. In addition to outcome prediction, 210 
the GBDT analysis with Shapley value explanations yielded the impact of each feature on both 211 
death and ICUA outcome for each single patient (summarised in Figures S3 and S4). 212 
We contrasted the Shapley values for impacts on death and ICUA in Figure 4. All patients with 213 
obesity, serious mental illness, immunosuppressing treatment, male sex, asymptomatic 214 
admission, and those whose self-reported ethnicity was other black, Indian, black Caribbean, 215 
other Asian, other white, and NA had concordant impacts to death and ICU admission. In 216 
almost all asthma patients, it is possible to appreciate negative impact on death and positive 217 
impact on ICUA. Patients with type-1 diabetes, chronic renal disease, or chronic neurological 218 
disease show positive association with death and negative association with ICUA outcome, 219 
although with very dispersed Shapley value distributions. Upon visual inspection, the scatter 220 
points for chronic liver disease, type-1 diabetes, chronic neurological, and chronic heart 221 
comorbidities show two (or more) clusters with respect to the impact on death. The 222 
hypertension scatter plot displays a neat partition with respect to the impact on ICUA 223 
outcome, showing that this variable was associated with ICUA. Its impact on death is less 224 
clear, with patients having discordant or concordant Shapley values for death. The cases of 225 
type-2 diabetes and chronic respiratory disease appear diametrically opposite to these, as all 226 
patients with such conditions had positive Shapley values for death with qualitatively 227 
different impacts on ICU outcome. 228 
Stratifing on ICUA yields marginally higher ROC-AUC scores (logistic regression 0.69 (95% CI 229 
0.66-0.72), GBDT 0.70 (95% CI 0.67-0.72) compared to death prediction obtained without 230 
ICUA prediction. In fact, ICUA is a very strong predictor of death (OR 2.25, 95% CI 2.04-2.48) 231 
but is markedly correlated to other features (Figure 1). The full results are summarised in 232 
Figures S5 and S6, and Table S1. 233 
The features were ranked according to their median ORs and their importance scores Imp 234 
(defined in methods), showing that these two are ordinally associated in both death 235 
(Spearman’s ρ=0.47, P=0.005) and ICUA outcomes (Spearman’s ρ=0.97, P=13×10-22), as shown 236 
in Figure 5. The explanation model for the GBDT was therefore largely consistent with the 237 
interpretable logistic linear model. The analysis of SHAP main effect also revealed the non-238 
linear relations between outcomes and the age and admission day (Figures 6 and 7). The 239 
probability of death rose above 30 years of age. Likelihood of ICU admission decreased 240 
markedly above 60. 241 
Discussion 242 
This cohort study investigated the association between patient characteristics (demographics 243 
and comorbidities) and severe outcomes with COVID-19 using a large national dataset in 244 
England (the CHESS database). Our findings on many factors were largely consistent with the 245 
patterns observed worldwide in studies on patients infected with SARS-CoV-220–32. Both 246 
logistic and GBDT models predicted admission to ICU more accurately than death. 247 
Obese patients were approximately 3.4-fold more likely to be admitted to ICU (the strongest 248 
association for any co-morbid condition), while the association with mortality was small and 249 
non-significant (OR 1.16, BH test).  In a US study involving 3615 patients, patients with a body 250 
mass index (BMI) between 30 and 35 were 2-fold more likely to reach the ICU and those with 251 
a  BMI of over 35 were 3-fold more likely, when compared to BMIs of less than 3020. These 252 
very high levels of ICUA in our and other works, as well as the contrastingly weaker association 253 
with COVID-19 mortality, could be explained by clinicians tending to, relatively, over-admit 254 
obese patients to ICU. It could reflect ICUA being very effective in reducing mortality in this 255 
group and is an important area for further research33. Hypertension, and asthma were 256 
associated with ICU admission but not death. Others have reported increased risk of severe 257 
COVID-19 among asthmatics, with the increase driven only by patients with non-allergic 258 
asthma25. Hypertension has been associated with severe COVID-19 disease in previous 259 
univariable studies but there is no clear evidence that hypertension is an independent risk 260 
factor27. 261 
Black or Asian minority ethnic groups showed higher odds of death and substantially higher 262 
odds of ICU admission in our data compared to white British patients. Similar findings to ours 263 
have been demonstrated UK-wide. Multivariable analyses from large multi-ethnic cohorts 264 
have suggested that Asian and black patients group experienced an excessive level of 265 
mortality, hospital admission, and intensive care admission even when differences in age, sex, 266 
deprivation, geographical region, and some key comorbidities were taken into 267 
account5,26,28,29. White Irish ethnicity was non-significantly associated with lower risk of death 268 
(OR 0.49, BH test). This finding, adjusted for all covariates, echoes findings in an earlier study 269 
comparing death rates standardised for age and region using census data28. Chinese ethnicity 270 
predicted ICU admission (OR 10.22 with respect to the white British baseline) most strongly, 271 
followed by black Caribbean (OR 5.25). For these and other minority groups the association 272 
with ICU admission far exceeded that of death. An unrecorded or unknown ethnicity was 273 
strongly negatively associated with ICU admission, but not strongly associated with death. 274 
This may indicate increased recording of ethnicity on ICU admission, a potential cause of bias 275 
in estimating true differences in risk of ICU admission across ethnicities. 276 
Age, type-1 diabetes, and neurological, heart, and respiratory diseases were negatively 277 
associated with ICU admission but not death.  Age and chronic respiratory disease were 278 
strongly positively associated with death.  Data gathered across the USA showed that deaths 279 
are 90 times higher in the 65-74 age group than the 18-29 age group and 630 times higher in 280 
the 85 and older group34. This may reflect judgements of limited capacity to benefit from ICU 281 
admission due to age and some co-morbidities. Type-2 diabetes is broadly reported to be 282 
associated with poor outcome in COVID-19 patients, while studies reporting outcome for 283 
type-1 diabetes are rare30,31. A national general practice based analysis in England 284 
demonstrated that both type-1 and type-2 diabetes are associated with increased risk of in-285 
hospital death with COVID-1932. Our multiply adjusted analysis of the CHESS dataset 286 
confirmed that type-2 diabetes had a strong association with mortality (and non-significant 287 
association with ICU admission), while type-1 diabetes’ association was positive but not 288 
statistically significant. On the other hand, type-1 diabetes was negatively associated with 289 
ICUA outcome. There is uncertainty regarding the effect of diabetes and glycaemic control on 290 
COVID-19 outcome. Whilst some suggest a 3-fold increase in intensive care admission and 291 
death22, others found no association between glycaemic control and severe outcome24. 292 
Potential mechanisms for effects could include hyperinsulinemia or the interaction of SARS-293 
CoV-2 with ACE2 receptors expressed in pancreatic β cells30,35. 294 
Male sex was positively and similarly associated with both ICU admission and death. The 295 
increased risk of male deaths is consistent with worldwide data, in which, on average, 1.4-296 
fold more men than women have died from SARS-CoV2, with some countries reporting 297 
greater than 2-fold male deaths36. Increased expression of the ACE2 receptor may occur in 298 
men and has been suggested as a possible explanation for this finding23. Asymptomatic 299 
testing and pregnancy demonstrated a strong negative association with both death and ICU 300 
admission. These results were expected in view of NHS trusts undertaking surveillance swabs 301 
for asymptomatic people, including among elective hospital admissions.  302 
Different machine-learning models have been leveraged to predict COVID-19 patients at risk 303 
of sudden deterioration. A study over 162 infected patients in Israel demonstrated that 304 
artificial intelligence may allow accurate risk prediction for COVID-19 patients using three 305 
models (neural networks, random trees, and random forests)37; a random forest model was 306 
used over 1987 patients for early prediction of ICU transfer38; the GBDT model was deployed 307 
on blood-sample data from 485 patients in Wuhan, China39; GBDT models outperformed 308 
conventional early-warning scoring systems for ventilation requirement prediction over 197 309 
patients40; deep learning and ensemble models were reported to perform well for early 310 
warning and triaging in China9,41. These models are very complex, but evidence indicates that 311 
mortality predictions can be obtained from more parsimonious models, upon selecting the 312 
most important features, thus facilitating more efficient implementation of machine-learning 313 
in clinical environments42. Despite these successes, prediction models have been found 314 
overall to be poorly reported and at high risk of bias in a systematic review43. A 315 
comprehensive list of relevant works is out of the scope of this paper, but it is worth 316 
underlining that machine-learning methods typically excel in outcome prediction but lack 317 
ease of interpretation of the result. In this study, we bridged the gap between performance 318 
and interpretability in machine learning for poor outcome predictions in COVID-19 patients. 319 
We trained GBDT models (see methods section) and extracted not-only their predictions, but 320 
also the extent to which each potential risk factor contributed to the prediction overall (thus 321 
permitting comparisons with the more easily-interpretable logistic regression model) and for 322 
each patient. So-called “Shapley values” quantify such information, as summarised in Figure 323 
S3 and S4 for death and ICU respectively. 324 
Overall, the association of patient features with the final outcome (measured by the SHAP 325 
importance scores Imp, see methods and Figure 5) is consistent with the logistic regression 326 
results, although the two models are intrinsically different. Moreover, for each feature, we 327 
derived an individual Shapley value for each patient, allowing us to consider the variation in 328 
effects among patients. As a first example, we discuss interpretation of type-2 diabetes. In 329 
the summary plots of Figures 4, S3, and S4, the red markers correspond to type-2 diabetes 330 
patients and blue to patients without type-2 diabetes. In the summary plot for death outcome 331 
(Figure S3, see also Figure 4), the red and blue markers are grouped into two distinct clusters. 332 
All the type-2 diabetes patients had positive Shapley values, thus showing that such a 333 
comorbidity was always associated with death, while all the other patients had nearly zero 334 
Shapley values. Conversely, in the summary plot for ICUA outcome (Figure S4, see also Figure 335 
4), the red markers appear scattered. Some T2-diabetes patients had positive Shapley values 336 
(positive association with ICU admission) while others had negative values (a negative 337 
association with ICU admission). The summary plots thus show not only the overall 338 
importance of a potential risk factor, but also its range of effects over the patients. In this 339 
case our interpretation is that although consistently increasing the risk of death, the presence 340 
of type 2 diabetes had more variable impact on decision making around ICU admission, in 341 
some cases apparently adding to the case for admission and in some cases diminishing it. 342 
Being male was positively associated with both death and ICU admission. Its impacts were 343 
concordant in sign and confined within a narrow range of values. Conversely, for example, 344 
chronic renal disease and immunosuppressive treatment had low impact on predicting death 345 
for some patients, but very high impact for others, perhaps reflecting that these categories 346 
comprise a number of diverse conditions and therapies. Considering ethnicity, most minority 347 
groups were consistently and positively associated with ICUA but the impact attributed to 348 
Pakistani ethnicity were much more variable. 349 
Shapley value analysis of the GBDT model also excels in explaining the nonlinear relations 350 
between covariates and their importance to outcome prediction. In Figure 6A, the predicted 351 
probability of death is shown to increase with age, in part due to increasing presence of 352 
comorbidities which are correlated with increasing age (Figure 1). In fact, the isolated effect 353 
of age (the SHAP main effects for age), illustrated in Figure 6C, shows a sharp rise from age 354 
30 even if it is stripped from the interactions with the other factors. For ICUA, the SHAP main 355 
effect for age abruptly drops and even reverses from the 60th year of age (Figure 7). The 356 
abruptness may suggest an age threshold is being applied in clinical decision making on ICU 357 
admission. 358 
During the first peak of COVID-19 epidemic healthcare services were under variable strain, 359 
and clinical expertise growing over time. Declining in-hospital mortality was observed in 360 
Italy44 and England45 during the first pandemic peak. This may reflect a mix of changing 361 
pressure, developing clinical expertise and variable follow up time following admission. We 362 
included the patient’s admission day in our models to allow for these effects in adjustment 363 
(logistic regression) and attribution of impact (machine learning). Hospital admission later 364 
than March decreased both death and ICUA.  These results mirror the PDPs outlined in Figures 365 
7 and 8 A-B, showing that a local explanation technique such as the Shapley value analysis 366 
supersedes and is consistent with the global explanation of the PDPs. The performance gains 367 
of the GBDTs here are small, in part due to the fact that all but two predictors (age and 368 
admission date) are binary. Indeed, the logistic model predictions depend on a linear 369 
combination of the predictor values, which is adequate if all the predictors are binary and the 370 
classes are linearly separable. The similarity in the predictive power for these specific cases 371 
should not shadow the other advantages of the GBDTs (including their greater generality and 372 
their ability of detecting non-linearity and variation in predictive effect). 373 
While all our models had excellent performances, it is worth noting that prediction of ICUA 374 
outcome was significantly better than death alone prediction for both. Including laboratory 375 
test results in the predictor variable may improve death prediction46. 376 
In conclusion, this study confirms that, in hospitalised patients, the risk of severe COVID-19, 377 
defined as either death or transfer to intensive care unit, is strongly associated with known 378 
demographic factors and comorbidities. We found that the association of these variables with 379 
death was often qualitatively and quantitatively different from their association with ICU 380 
admission. This was consistently derived by means of two different predictive models, i.e., 381 
the standard logistic and the GDBT machine-learning models. The Shapley value explanation 382 
of the latter model also highlights the sometimes variable impact of each factor for each 383 
patient. These results allow an insight into the variable impact of individual risk factors on 384 
clinical decision support systems. We suggest that these should not only grant the optimal 385 
average prediction, but also provide interpretable outputs for validation by domain experts. 386 
Shapley values may also support analytical approaches to address the problem of 387 
characterising the group of patients for whom a prediction is incorrect. This is an important 388 
additional potential area for research and application. Shapley-value analyses allow clinical 389 
interpretation of the results from a complex machine-learning model such as the GBDT. Using 390 
these we have derived importance scores which are consistent with the better known ORs as 391 
an overall assessment of an average effect but can additionally display the extent to which 392 
this average effect is consistent across patients or highly variable among different patient 393 
groups. We recommend the wider adoption of Shapley-value analyses to support 394 
interpretation of ML outputs in clinical decision making given this capacity to communicate 395 
the variation in the effects of predictive variables. These aspects are particularly valuable to 396 
tackle COVID-19, a complex disease that can cause a variety of symptoms and clinical 397 
outcomes, depending on the patients' conditions, and rapidly overwhelm healthcare systems, 398 
thus requiring large-scale automated decision systems. 399 
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Tables and figures 527 
 528 
Table 1: Fraction of patients in cohort by sex and comorbitidies. 529 
Sex male 0.593 
Other comorbidity 0.315 
Hypertension 0.270 
Chronic heart disease 0.161 
T2 diabetes 0.159 
Chronic respiratory disease 0.109 
Obesity (clinical) 0.106 
Chronic neurological cond. 0.087 





Immunosuppression disease 0.027 
Asymptomatic testing 0.021 
Chronic liver 0.017 
T1 diabetes 0.012 
Pregnancy 0.006 
Serious mental illness 0.006 




Table 2: Fraction of patients in cohort by ethnicity. 533 
White British 0.598 
Eth. NA 0.134 
Eth. unknown 0.102 
Other white 0.026 
Other Asian 0.024 
Other ethn. 0.024 
Indian 0.024 
Pakistani 0.019 
Black African 0.013 
Black Caribbean 0.010 
Other black 0.006 
White Irish 0.004 
Other mixed 0.004 
Bangladeshi 0.004 
White and black 
Caribbean 0.003 
Chinese 0.003 
White and black African 0.002 




Figure 1. Correlation heatmap between self-defined ethnicities and pre-existing conditions. 537 
Color shades from blue to red correspond to increasing values of Person correlation 538 
coefficient (white: no correlations are present). NA labels inpatients who did not identify 539 
themselves with any ethnicity.  540 
 541 
 542 
Table 3. Estimated odd ratios (ORs) from adjusted logistic regressions and importance (Imp) 543 
scores of death and intensive-care unit admission (ICUA) outcomes. P values that do not test 544 
significant according to the Benjamini-Hochberg procedure are marked with a dagger(†). 545 
 Death outcome ICUA outcome  
OR 95% CI Pr(>|z|) Imp OR 95% CI Pr(>|z|) Imp 
Comorbidities:                 
Immunosuppr. disease 1.392 1.1-1.76 0.006 0.25 0.826 0.63-1.07 0.157† -0.13 
T2 diabetes 1.307 1.17-1.46 0.000 0.18 1.018 0.9-1.15 0.778† -0.05 
T1 diabetes 1.228 0.85-1.77 0.275† 0.07 0.414 0.27-0.63 0.000 -1.09 
Chronic liver 1.215 0.89-1.64 0.209† 0.11 1.146 0.83-1.58 0.406† 0.00 
Chronic respiratory 
disease 1.188 1.05-1.35 0.008 0.08 0.830 0.72-0.96 0.011 -0.21 
Obesity (clinical) 1.163 1.01-1.33 0.030† 0.08 3.371 2.9-3.92 0.000 0.87 
Serious mental illness 1.087 0.63-1.82 0.755† 0.04 2.575 1.5-4.46 0.001 0.49 
Chronic renal disease 1.081 0.94-1.25 0.284† 0.15 0.672 0.57-0.79 0.000 -0.21 
Chronic neurological 
cond. 1.064 0.93-1.22 0.381† 0.08 0.322 0.27-0.39 0.000 -1.01 
Chronic heart disease 1.017 0.91-1.14 0.770† 0.05 0.481 0.42-0.55 0.000 -0.45 
Hypertension 1.003 0.91-1.1 0.958† 0.00 1.578 1.42-1.76 0.000 0.30 
Other comorbidity 0.871 0.8-0.95 0.003 -0.05 1.314 1.19-1.45 0.000 0.21 
Asthma 0.869 0.75-1.01 0.070† -0.10 1.512 1.29-1.77 0.000 0.25 
Ethnicities:            
White and Asian 2.401 0.92-6.11 0.066 0.00 2.451 0.95-6.91 0.073† 0.00 
Other black 2.204 1.34-3.61 0.002 0.42 3.583 1.96-7.03 0.000 1.18 
White and black 
Caribbean 1.996 1.03-3.83 0.038 0.00 2.570 1.23-5.84 0.017 0.76 
White and black 
African 1.842 0.78-4.15 0.149† 0.00 3.439 1.33-10.75 0.018 0.61 
Indian 1.838 1.42-2.37 0.000 0.41 2.443 1.86-3.23 0.000 0.76 
Chinese 1.784 0.85-3.71 0.122† 0.00 10.224 3.92-35.06 0.000 1.85 
Pakistani 1.709 1.28-2.28 0.000 0.33 1.158 0.87-1.54 0.314† 0.04 
Other mixed 1.584 0.78-3.07 0.187† 0.00 3.069 1.5-6.81 0.003 1.03 
Black Caribbean 1.499 1.02-2.2 0.040 0.29 5.247 3.26-8.84 0.000 1.60 
Bangladeshi 1.376 0.7-2.61 0.338† 0.00 3.086 1.6-6.32 0.001 1.11 
Other Asian 1.265 0.97-1.65 0.084 0.19 3.183 2.41-4.25 0.000 1.01 
Other white 1.076 0.83-1.39 0.585† 0.03 2.721 2.09-3.57 0.000 1.01 
Eth. unrecorded 0.969 0.86-1.09 0.607† -0.05 0.160 0.13-0.19 0.000 -1.78 
Other eth. 0.966 0.72-1.28 0.809† 0.03 3.711 2.75-5.08 0.000 1.03 
Black African 0.922 0.62-1.33 0.672† -0.04 4.170 2.78-6.46 0.000 1.35 
Eth. unknown 0.859 0.75-0.99 0.032† -0.10 0.770 0.67-0.88 0.000 -0.26 
White Irish 0.493 0.25-0.92 0.032† -0.19 0.933 0.51-1.68 0.818† 0.00 
Other:                 
Sex unknown 1.900 0.76-4.74 0.165† 0.00 0.395 0.08-1.45 0.205† 0.00 
Age (x10 years) 1.560 1.51-1.61 0.000 0.02 0.764 0.74-0.78 0.000 -0.02 
Sex male 1.543 1.42-1.68 0.000 0.13 1.735 1.59-1.89 0.000 0.16 
Immunosuppr. 
treatment 1.229 0.98-1.54 0.072† 0.10 1.793 1.41-2.28 0.000 0.55 
Admission day 0.795 0.76-0.83 0.000 -0.24 0.666 0.64-0.7 0.000 -0.39 
Pregnancy 0.714 0.3-1.52 0.414† 0.00 0.339 0.2-0.57 0.000 -0.19 
Asymptomatic testing 0.291 0.18-0.45 0.000 -0.82 0.517 0.35-0.74 0.000 -0.44 
  546 
 547 
Figure 2. Contrasting odd ratios (ORs) of death with ORs of intensive care unit admission 548 
(ICUA). Features are grouped into comorbidities, self-defined ethnicities, and others (top to 549 
bottom). For binary variables, marker sizes are proportional to the frequencies of the 550 
exposure. Error bars are 68% confidence intervals (CIs). Gray and white regions correspond 551 
to discordant and concordant associations. The figure highlights mismatches in the ORs of a 552 
number of variables, e.g., asthma and “other comorbidity” were risk factors for ICUA but 553 
protective for death outcome. Chronic respiratory disease was a risk factor for death but 554 
negatively associated with ICU admission. For most ethnicities the ORs of death and ICUA 555 
were concordant in sign but of different magnitude. 556 
Abbreviations: 557 
Mental ill.: serious mental illness 558 
Resp. dis.: respiratory disease 559 
Neuro. dis.: neurological disease 560 
Immunos. dis.: immunosuppression due to disease 561 
T2D: type-1 diabetes 562 
T1D: type-2 diabetes 563 
Eth. NA: ethnicity unrecorded 564 
Immunos. treat.: immunosuppression due to treatment 565 









Figure 3. ROC curves (C-statistics) of the logistic regression classifiers over the validation set. 575 
Confidence intervals are obtained by means of bootstrapping. 576 
577 
Table 4. Variance inflation factors (VIFs) for the logistic regressions. VIF scores are always 578 
smaller than two, excluding serious collinearity issues.  579 
 
VIF death VIF ICUA 
Age (x10 years) 1.29 1.19 
Hypertension 1.26 1.28 
Chronic heart disease 1.25 1.21 
T2 diabetes 1.19 1.18 
Other comorbidity 1.18 1.18 
Chronic renal disease 1.15 1.14 
Obesity (clinical) 1.13 1.07 
Eth. NA 1.12 1.07 
Chronic respiratory disease 1.10 1.10 
Chronic neurological cond. 1.08 1.04 
Admission day 1.07 1.13 
Eth. unknown 1.07 1.07 
Immunosuppr. treatment 1.06 1.06 
Immunosuppr. disease 1.05 1.05 
Asthma 1.05 1.05 
Other Asian 1.05 1.03 
Sex male 1.05 1.03 
Indian 1.04 1.03 
Pakistani 1.04 1.04 
Asymptomatic testing 1.04 1.09 
Other ethn. 1.04 1.02 
Other white 1.03 1.02 
Black African 1.03 1.02 
Other black 1.02 1.01 
Chronic liver 1.02 1.02 
Black Caribbean 1.02 1.01 
T1 diabetes 1.02 1.02 
Serious mental illness 1.01 1.02 
Other mixed 1.01 1.01 
White and black Caribbean 1.01 1.01 
Sex unknown 1.01 1.01 
Bangladeshi 1.01 1.01 
Pregnancy 1.01 1.03 
White and Asian 1.01 1.01 
White and black African 1.01 1.00 
Chinese 1.01 1.00 
 580 
  581 
 582 
  583 
Figure 4. Contrasting Shapley values for impact on death and intensive-care unit admission 584 
ICUA for all variables included in this study. Each marker in the scatter plots corresponds to 585 
an in-patient. Colors from red to blue indicate the value of the underlying variable (in binary 586 
variables, red color means feature is present, blue otherwise; in age feature, red to blue 587 
shades correspond to old to young ages; in admission day, red to blue shades correspond to 588 
early to late dates). The explanation models assigned a concordant (discordant) impact on 589 
death and ICUA to the patients in the white (grey) regions. The scatter plots expose not only 590 
the importance of a potential risk factor but also its range of effects over the cohort. All 591 
patients with immunosuppression disease, type-2 diabetes, liver and respiratory disease, 592 
and Pakistani self-defined ethnicity had positive Shapley values from death, with impact on 593 
ICU ranging from negative to positive values, thus suggesting that these conditions were 594 
always leaning towards death but sometimes not consistently towards ICUA. Conversely 595 
hypertension always have positive impact on ICUA whilst can either have positive or 596 
negative impact on death for different patients. The Shapley values for death for many 597 
features appear clustered (T1 diabetes, chronic liver, neurological, and hearth disease 598 
comorbidities), thus suggesting the presence of different groups under the same labels with 599 
different effect on patient health. Inspection of the age pattern suggests the presence of a 600 
group of young patients (blue markers) with negative impact on both age and ICUA 601 
outcome, old-age patients with positive impact on death and negative impact on ICUA 602 
outcome, and intermediate-age patients with impacts negative on death and positive on 603 
ICUA outcome. 604 
For abbreviations, see the caption of Figure 2. 605 
 606 
 607 
  608 
 609 
Figure 5. SHAP importance scores from the explaination model for GBDT vs logarithm of 610 
odd-rations (ORs) from logistic regression for death (A) and intensive-care unit (ICU) 611 
admission (B). Each point represents a feature (see Table 3). Red markers correspond to the 612 
features whose association with the outcome was not significant according to the logistic 613 
regression . The x-axis errorbars comprise 68% confidence intervals. The SHAP importance 614 
Imp allows us to assess to what extent a feature contributes to the GBDT prediction. This 615 
plot shows that these are consistent with the well-known logistic regression coefficients, 616 
despite the underlying models used to generate these two quantities are fundamentally 617 
different.  618 
 619 
 620 
Figure 6. A-B) Partial dependence plots (PDPs) and probability of death predicted by GBDT 621 
for each patient in training set. C-D) SHAP main effect for age and admission date. These 622 
effects can be ascribed to the age/admission date alone, regardless of their covariates. The 623 
strong pattern in the main effect for admission date highlights the importance of 624 




Figure 7. A-B) Partial dependence plots (PDPs) and probability of intensive-care unit 629 
admission predicted by GBDT for each patient in training set. C-D) SHAP main effect for age 630 
and admission date.  631 
 632 
